Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/24/2007CN100344296C Chimonanthus nitense leaf drop pills for preventing common cold and preparation technique thereof
10/24/2007CN100344295C Ganoderma lucidum capsule of lycopene
10/24/2007CN100344293C Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2007CN100344289C Pollen pini soft capsule and its preparation method
10/24/2007CN100344288C Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
10/24/2007CN100344287C Biodegradable polyester fluorouracil microglobule and its preparation method
10/24/2007CN100344286C Slow controlled released combsn. preparation of semisolid framework of containing glipizide
10/24/2007CN100344285C Water soluble preparation of domperidone and production thereof
10/24/2007CN100344283C Abidor inclusion compound
10/24/2007CN100344282C Method for preparing rifamicina injecta
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/24/2007CN100344277C Nano-magnetic medicinal microglobule, its preparation method and application
10/24/2007CN100344234C Pesticidal formulation
10/24/2007CA2586236A1 Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
10/23/2007USRE39892 Pessaries or vaginal tablets of two layers of lactobacilli brevis and salivarius, in bound form, so that the release velocity of bacteria of the outermost layer is greater than the release velocity of bacteria of the innermost layer.
10/23/2007US7285668 At a concentration of 0.1-0.5 g/ml. at 0-35 degrees C. from a C1-4 alkyl acetate solution; preservation stability
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285621 Multiple branch peptide construction
10/23/2007US7285540 hepatocyte growth factor gene as drug; topical applying ; side effect reduction; cardiovascular disorders
10/23/2007US7285517 Warming and nonirritating lubricant compositions and method of comparing irritation
10/23/2007US7285303 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate
10/23/2007US7285290 Hydrophilized powder and a composition comprising the same
10/23/2007US7285289 Nanoparticle vaccines
10/23/2007US7285283 Paper substrate impregnated with an emulsion having a polyol, poly-12-hydroxystearate emulsifier, an oil component and water
10/23/2007US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007US7285266 Cell-polymer fiber compositions and uses thereof
10/23/2007CA2406849C Stabilized liquid preparation
10/23/2007CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/23/2007CA2221900C Use of trospium chloride and 2-component system for the same
10/23/2007CA2177961C Use of dimeticone for treating aphthae and stomatitis
10/18/2007WO2007118063A1 Fast release paracetamol tablets
10/18/2007WO2007118033A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
10/18/2007WO2007117923A2 Compositions including relatively water insoluble/unwettable drugs and methods for using same
10/18/2007WO2007117771A2 Time-release compositions for delivery of [cr3o(carboxylate)6(h2o)3]+
10/18/2007WO2007117629A2 Impact of calcium phosphate complex on dental caries
10/18/2007WO2007117628A2 Impact of calcium phosphate complex on dental caries
10/18/2007WO2007117627A2 Calcium phosphate complex and salts in oral delivery systems
10/18/2007WO2007117605A2 Novel spill-resistant formulations comprising hydrocolloidal polymers
10/18/2007WO2007117581A2 Stabilized transdermal bupropion preparations
10/18/2007WO2007117550A2 Methods for coacervation induced liposomal encapsulation and formulations thereof
10/18/2007WO2007117509A2 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007WO2007117469A2 Compositions of less immunogenic and long-circulating protein-lipid complexes
10/18/2007WO2007117435A2 Coatings formed from stimulus-sensitive material
10/18/2007WO2007117314A2 Bupropion controlled release formulations and methods of making
10/18/2007WO2007117173A1 Fluid dispensing system, methods and products
10/18/2007WO2007117023A1 Process and apparatus for producing liposome dispersion
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116959A1 Microneedle device and transdermal administration device provided with microneedles
10/18/2007WO2007116954A2 Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer
10/18/2007WO2007116951A1 Drug-immobilized inorganic nanoparticle
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116915A1 Liquid drug preparation for oral administration packaged in a container having discharge unit
10/18/2007WO2007116632A1 Microparticles, microparticle dispersion and method and apparatus for producing the same
10/18/2007WO2007116062A1 Capsules containing plant preparations
10/18/2007WO2007115635A1 Biguanide-containing liposomes
10/18/2007WO2007100757A3 Transdermal therapeutic system comprising scopolamine
10/18/2007WO2007096906A3 Novel buccoadhesive compositions and process of preparation thereof
10/18/2007WO2007093425A3 Storage-stable oral dosage form of amoxicillin and clavulanic acid
10/18/2007WO2007092829A3 Stabilized compositions of proteins having a free thiol moiety
10/18/2007WO2007090846B1 Haemostatic agent
10/18/2007WO2007083323A3 Modified release oral dosage form comprising desmopressin
10/18/2007WO2007067470A3 Benzimidazole non-aqueous compositions
10/18/2007WO2007059836A3 Compositions containing proteins for the transfer/recycling of structurally modified lipids, and the applications thereof
10/18/2007WO2007052121A3 Multi-layered coating technology for taste masking
10/18/2007WO2007036952B1 Novel sustained release dosage form
10/18/2007WO2007031933A3 Stable pharmaceutical composition comprising a pyrimidine-sulfamide
10/18/2007WO2007024574A3 Topical formulations of histone deacetylase inhibitors and methods of using the same
10/18/2007WO2007022924B1 Pharmaceutical compositions with melting point depressant agents and method of making same
10/18/2007WO2007022165B1 Factor xa inhibitor inclusion complex with cyclodextrin
10/18/2007WO2007014210A3 Compositions and methods for the reduction of post-operative pain
10/18/2007WO2006084164A8 Gastric retention and controlled release delivery system
10/18/2007US20070244469 Miniature infusion pump for a controlled delivery of medication
10/18/2007US20070244448 Device And Method For Delivering Or Withdrawing A Substance Through The Skin
10/18/2007US20070244299 Method of Stabilizing Proteins
10/18/2007US20070244294 Polyamide-polyether block copolymer
10/18/2007US20070244259 Ph and Temperature Sensitive Hydrogels
10/18/2007US20070244203 Controlled-Release Composition for Topical Application and a Method of Delivering an Active Agent to a Substrate
10/18/2007US20070244093 Quetiapine formulations
10/18/2007US20070244049 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/18/2007US20070243311 Weight management system for obese animals
10/18/2007US20070243262 Stable S-nitrosothiol formulations
10/18/2007US20070243261 Biocompatible microcapsules
10/18/2007US20070243260 Treatment of Childhood Asthma
10/18/2007US20070243259 Nanoparticles for protein/peptide delivery and delivery means
10/18/2007US20070243258 Method and apparatus for forming crosslinked chromonic nanoparticles
10/18/2007US20070243257 Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose
10/18/2007US20070243256 Polyesteramide platform for site specific drug delivery
10/18/2007US20070243255 Multifunctional supramolecular hydrogels as biomaterials
10/18/2007US20070243254 Novel drug compositions and dosage forms of topiramate
10/18/2007US20070243253 Colonic drug delivery formulation
10/18/2007US20070243252 Oral Dosage Formulations and Methods of Preparing the Same
10/18/2007US20070243251 Dosage Forms Containing A PPI, NSAID, and Buffer
10/18/2007US20070243250 Oral Dosage Formulations and Methods of Preparing the Same
10/18/2007US20070243249 Novel formulation of pyridoxal-5'-phosphate and method of preparation
10/18/2007US20070243248 Rapidly disintegrating solid oral dosage form of liquid dispersions
10/18/2007US20070243247 Dosage Form Containing The Active Ingredient Cholylsarcosine
10/18/2007US20070243246 Lubricious coatings for pharmaceutical applications
10/18/2007US20070243245 Oral Dosage Formulations, Methods of Preparing the Same, and Methods of Reducing Food Effects on Drug Release
10/18/2007US20070243244 Treating antibiotic-associated pseudomembranous colitis caused by C. difficile, and enterocolitis caused by S. aureus and associated MRSA strains
1 ... 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 ... 2991